HUM Humana
Q2 2025 10-Q
Humana (HUM) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 30, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ2 2025 10-Q
Risk Factors
- • New risk: Additional impairment charges of $32M for indefinite-lived intangible assets in H1 2025, none recorded in same period 2024, triggered by value creation initiatives
- • Most material update: Shift in Medicare Part D benefit design due to Inflation Reduction Act of 2022 causing more level prescription costs and increased plan liabilities risk
Quarterly Financial SummaryXBRL
Revenue
$32.4B
Net Income
$545M
Net Margin
1.7%
Source: XBRL data from Humana Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Humana Quarterly Reports
Get deeper insights on Humana
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.